SI-BONE, Inc. (SIBN)

Market Cap	681.80M
Revenue (ttm)	167.18M
Net Income (ttm)	-30.91M
Shares Out	42.45M
EPS (ttm)	-0.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	459,637
Open	16.38
Previous Close	16.36
Day's Range	15.65 - 16.49
52-Week Range	11.70 - 19.16
Beta	1.17
Analysts	Strong Buy
Price Target	24.50 (+52.55%)
Earnings Date	Feb 24, 2025

About SIBN

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 17, 2018
• Employees: 349
• Stock Exchange: NASDAQ
• Ticker Symbol: SIBN
• Website: https://si-bone.com

Financial Performance

In 2024, SI-BONE's revenue was $167.18 million, an increase of 20.37% compared to the previous year's $138.89 million. Losses were -$30.91 million, -28.67% less than in 2023.

Analyst Forecast

According to 6 analysts, the average rating for SIBN stock is "Strong Buy." The 12-month stock price forecast is $24.5, which is an increase of 52.55% from the latest price.

Price Target

$24.5

(52.55% upside)

Analyst Consensus: Strong Buy